介质细胞干细胞在治疗COVID-19中的作用
Bei-Cyuan Guo1, Kang-Hsi Wu2,3, Chun-Yu Chen4,5
1Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan.
International journal of molecular sciences
|October 14, 2023
概括
介质细胞干细胞 (MSCs) 通过减少炎症和帮助组织修复,在治疗严重的COVID-19和急性呼吸困扰综合征 (ARDS) 中表现有前途. 需要进一步的研究来优化MSC治疗以获得更好的患者结果.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 传染性疾病 传染性疾病
背景情况:
- COVID-19引起严重的呼吸道和多器官损伤,通常是由于细胞因子风暴.
- 急性呼吸困扰综合征 (ARDS) 是严重的COVID-19的一个关键并发症.
- 介质细胞干细胞 (MSCs) 具有抗炎和再生性质.
研究的目的:
- 评估MSCs在治疗严重的COVID-19和ARDS中的有效性和安全性.
- 确定基于MSC的COVID-19疗法未来研究的关键领域.
主要方法:
- 对COVID-19和ARDS的MSC积累证据的审查.
- 对MSC的免疫调节和再生机制的分析.
主要成果:
- 在严重的COVID-19和ARDS中,MSC在减轻炎症和促进组织修复方面表现出显著的潜力.
- 现有证据支持MSC治疗的安全性和有效性.
结论:
- MSCs为严重的COVID-19和ARDS提供了一个有希望的治疗策略.
- 进一步的研究对于优化MSC注射途径,剂量和间隔至关重要.
- 研究儿科应用和管理肺外并发症对于完善MSC治疗至关重要.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


